Lopressor and Retinal vessel occlusion - a phase IV clinical study of FDA data

Summary:

Retinal vessel occlusion is reported as a side effect among people who take Lopressor (metoprolol tartrate), especially for people who are male, 60+ old, also take Aspirin, and have Diabetes.

The phase IV clinical study analyzes which people have Retinal vessel occlusion when taking Lopressor. It is created by eHealthMe based on reports of 32,072 people who have side effects when taking Lopressor from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Retinal vessel occlusion?

Retinal vessel occlusion (a blockage in one of the small arteries) is found to be associated with 469 drugs and 830 conditions by eHealthMe. Check the latest studies of Retinal vessel occlusion.

On Jul, 09, 2026

32,072 people reported to have side effects when taking Lopressor.
Among them, 16 people (0.05%) have Retinal vessel occlusion.

Could Lopressor cause Retinal vessel occlusion?

Among these 16 people:

What is the gender of people who have Retinal vessel occlusion when taking Lopressor? *

female: 50 %
male: 50 %

What is the age of people who have Retinal vessel occlusion when taking Lopressor? *

What are other drugs people take besides Lopressor? *

What are other side effects people have besides Retinal vessel occlusion? *

Blindness: 6 people, 37.50%
Cataract (clouding of the lens inside the eye): 3 people, 18.75%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 18.75%
Oesophagitis (inflammation of oesophagus): 3 people, 18.75%
Nausea And Vomiting: 3 people, 18.75%
Headache (pain in head): 3 people, 18.75%
Thrombocytopenia (decrease of platelets in blood): 3 people, 18.75%
Embolism Arterial (blood clot that has travelled through your arteries and become stuck): 3 people, 18.75%
Visual Field Defect: 3 people, 18.75%
Eye Haemorrhage (bleeding in the eye): 3 people, 18.75%

What are the existing conditions these people have? *

Diabetes: 4 people, 25.00%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 18.75%
High Blood Cholesterol: 3 people, 18.75%
Pain: 2 people, 12.50%
Anaemia (lack of blood): 2 people, 12.50%
Prostate Cancer: 1 person, 6.25%
Menopausal Symptoms: 1 person, 6.25%
Hepatitis C: 1 person, 6.25%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.25%
Erection Problems: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and have Retinal vessel occlusion?

- Check whether Retinal vessel occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopressor:

Lopressor (33,152 reports)

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (469 drugs)

Browse all the conditions that are associated with Retinal vessel occlusion:

Retinal vessel occlusion (830 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Lopressor) and Lopressor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.